Financial Daily from THE HINDU group of publications
Thursday, Oct 13, 2005


News
Features
Stocks
Shipping
Archives
Google

Group Sites

Industry & Economy - Packaging
Marketing - New Products & Services


Bilcare unveils clinical services facility in Pune

Our Bureau

Pune , Oct. 12

PHARMA packaging research and solutions company Bilcare has unveiled its clinical services facility here.

Dr Christoph Moeschli, Head, Clinical Packaging of Novartis Pharma AG Switzerland, inaugurated the new facility.

Talking to presspersons, Mr Mohan Bhandari, Chairman and Managing Director, Bilcare, said this facility would support pharma companies in packaging and distributing their clinical supplies and integrate their global clinical trial requirements efficiently.

The facility has been constructed near its existing unit at Rajgurunagar near Pune. Mr Bhandari said the core of the global clinical service included manufacturing, packaging, randomisation, storage and distribution, returns and destruction of clinical supplies.

He said the company was looking at a topline revenue of $25 million for the first year from these services. Mr Bhandari said the pharma spend on a global basis was about $500 billion, of which research and development took up about $100 billion. Out of this R&D spend, clinical trials accounted for $25 billion and clinical services about $3 billion. This was the market that Bilcare was targeting, he said.

Novartis Pharma is the first client for clinical services of the new facility, he said.

Mr Bhandari said Bilcare had made its first strategic acquisition outside the country by acquiring in July ProClinical (now called Bilcare Inc in the US) along with the distribution centres in major regions of the world. ProClinical is an established pharma research and clinical packaging services business in Pennsylvania.

He noted that this acquisition provided Bilcare an entry into the US pharma market. The 14-acre site is US Food and Drug Administration-approved and is also licensed by the Drug Enforcement Agency for handling controlled substances.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Tata Safari Dicor

Stories in this Section
What's causing the pollution


Twin-engined reverse monsoon in top gear
Gorgeous scene
Low tax-GDP ratio daunts India's quest to join developed world
China's growth projection to boost commodities
Bilateral trade with China up 40 pc in Q1
Rising health claims force insurers' rethink on TPAs
Rooms with a view
UK court restricts launch of Ranbaxy's cholesterol drug — Pfizer says ruling will protect UK turf from generic competition
New tonnage tax regime — Shipping Ministry takes hard stand on fleet acquisition clause
Draft circular on advertising services — Ad agencies may have to fork out more service tax
`Textile mills' operating profits rise due to drop in input costs'
Burning issue
38 pc consider multiple brands before vehicle purchase: J.D. Power
Leather design centre to be set up at NIFT
Corrugated box industry mulls hiking prices
Nasscom in pact with Canada peer
CCMB to make nano-biotech foray
Demand makes paint sector buck input costs pressure
Bilcare unveils clinical services facility in Pune
FICCI seeks more FDI in DTH, cable biz
Volkswagen team coming today
Franchise Expo in Delhi
In Hyderabad today
`FBT not in tune with spirit of liberalisation'
Kamal Nath to meet chiefs of export promotion councils


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line